Edition:
India

Harvard Bioscience Inc (HBIO.OQ)

HBIO.OQ on NASDAQ Stock Exchange Global Market

5.10USD
20 Jul 2018
Change (% chg)

$-0.05 (-0.97%)
Prev Close
$5.15
Open
$5.10
Day's High
$5.18
Day's Low
$5.10
Volume
8,124
Avg. Vol
52,273
52-wk High
$6.10
52-wk Low
$2.45

Latest Key Developments (Source: Significant Developments)

Harvard Bioscience Inc Files For Mixed Shelf Of Up To $50 Mln
Tuesday, 1 May 2018 

April 30 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING.  Full Article

Harvard Bioscience Says Co Entered Into A Financing Agreement
Saturday, 3 Feb 2018 

Feb 2 (Reuters) - Harvard Bioscience Inc ::HARVARD BIOSCIENCE INC - ON JAN 31, 2018, CO ENTERED INTO A FINANCING AGREEMENT - SEC FILING.HARVARD BIOSCIENCE INC - FINANCING AGREEMENT PROVIDES SENIOR SECURED CREDIT FACILITIES HAVING $64 MILLION TERM LOAN, $25 MILLION REVOLVING CREDIT LINE.  Full Article

Harvard Bioscience reports Q3 loss $0.01/shr
Friday, 27 Oct 2017 

Oct 26 (Reuters) - Harvard Bioscience Inc :Harvard Bioscience reports third quarter 2017 financial results.Sees Q4 2017 non-GAAP earnings per share $0.05 to $0.06.Sees Q4 2017 GAAP loss per share about $0.00 to $0.01.Q3 revenue $25.1 million versus i/b/e/s view $24.6 million.Q3 non-GAAP earnings per share $0.03.Q3 GAAP loss per share $0.01.Q3 earnings per share view $0.03 -- Thomson Reuters I/B/E/S.Harvard Bioscience Inc - ‍reaffirming its Q4 revenue guidance​.  Full Article

BRIEF-Harvard Bioscience Q1 GAAP Loss Per Share $0.11

* HARVARD BIOSCIENCE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS